In summary, given the robust role of the LHb in psychiatric disorders as well as the role of CB1R-mediated regulation of LHb activity, targeting the eCB system for ELS-induced psychiatric disorders is a potential therapeutic option. This evidence concerns the gene CNR1 and psychiatric disorder.